Aquestive Therapeutics, Inc.
Ticker: 1398733
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 13.82-4.4% | 14.45+12.8% | 12.81+28.1% | 10.00+14.7% | 8.72-35.6% | 13.54-32.6% | 20.10+66.8% | 12.05 |
| Total Income | 13.82-4.4% | 14.45+12.8% | 12.81+28.1% | 10.00+14.7% | 8.72-35.6% | 13.54-32.6% | 20.10+66.8% | 12.05 |
| EXPENSES | ||||||||
| Expenditure | 22.04+18.2% | 18.65-23.2% | 24.29+13.7% | 21.37-23.9% | 28.09+28.7% | 21.83+8.9% | 20.04-4.6% | 21.01 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||||||
| PBT | -22.86-183.6% | -8.06+47.8% | -15.45-14.0% | -13.55+40.9% | -22.93-99.2% | -11.51-318.5% | -2.75+78.6% | -12.83 |
| Net Profit | -22.86-183.6% | -8.06+47.8% | -15.45-14.0% | -13.55+40.9% | -22.93-99.2% | -11.51-318.5% | -2.75+78.6% | -12.83 |
| KEY METRICS | ||||||||
| OPM % | -59.51%-30.40pp | -29.10%+60.53pp | -89.63%+10.37pp | -100.00% | -100.00%-38.78pp | -61.22%-61.49pp | 0.27%+74.59pp | -74.31% |
| NPM % | -100.00%-44.23pp | -55.77%+44.23pp | -100.00% | -100.00% | -100.00%-15.01pp | -84.99%-71.33pp | -13.66%+86.34pp | -100.00% |
| EPS | -0.18-157.1% | -0.07+50.0% | -0.14+0.0% | -0.14+41.7% | -0.24-84.6% | -0.13-333.3% | -0.03+82.4% | -0.17 |
Corporate Events
Board MeetingAQST
202614Oct
Board Meeting
Election of Richard J. Daly as a director, effective October…
SEC Filing ↗ Board MeetingAQST
202610Jun
Board Meeting
2026 Annual Meeting of Stockholders voting results for direc…
SEC Filing ↗